Health Canada Warns About Risks of Purchasing Fake Semaglutide Drugs
Health Canada has issued a warning to Canadians about counterfeit weight loss medications being sold in stores and online. In the safety advisory, the health agency says fake versions of semaglutide and tirzepatide have been found online and in stores. The authorized version of the drugs are sold under brand names such as Ozempic, Wegovy, […]
Health Canada Warns About Risks of Purchasing Fake Semaglutide Drugs Health Canada has issued a warning to Canadians regarding counterfeit versions of semaglutide and tirzepatide, commonly known by brand names like Ozempic, Wegovy, and Zepbound. These fake medications have been discovered being sold both online and in physical stores. The health agency emphasizes that these counterfeit drugs have not undergone assessment for safety, effectiveness, or quality, posing significant health risks to consumers.
- Health Canada has issued a warning about counterfeit weight loss medications.
- Fake versions of semaglutide and tirzepatide have been found.
- Authorized versions are sold under brand names like Ozempic, Wegovy, and Zepbound.
- Counterfeit medications pose serious health risks as they are not assessed for safety, effectiveness, or quality.
- Semaglutide is used for type 2 diabetes and weight loss, mimicking the GLP-1 hormone.
No comments yet.
Write a comment